About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: May 2014
Weekly Roundup 5.30.14
This is just awful. A whole week without a posting. Not because I did not have anything to talk about, but because I did not have anything like time on my side. It was one of those weeks. I did … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 5.30.14
Weekly Roundup 5.23.14
We were all feeling a little pent up this Winter and delighted to see Spring. And what is more delightful than seeing others delighted? Check out the Weekly Roundup video of dairy cows greeting the meadow after a winter in … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 5.23.14
Media, Science and Emerging Pathogens – Communications in a Time of Outbreak
Accuracy and consistency in communications is always important. On important issues, misinformation can lead to serious consequences. That is especially true in the field of public health. In watching the media coverage of the outbreak of Middle East Respiratory Syndrome … Continue reading
Posted in Current Affairs
Comments Off on Media, Science and Emerging Pathogens – Communications in a Time of Outbreak
Weekly Roundup 5.16.14
The Weekly Roundup is late after a much-needed day of respite. Sorry about that. A little bit of Spring Fever mixed with a lot of need to catch up on things around home. In any case, there is a little … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 5.16.14
Looking Beyond Patient Engagement for Pharma and Social Media
As we wait for the anticipated guidance from FDA regarding the use of social media by the pharmaceutical industry, one of the many aspects discussed as been that of patient engagement with the industry. The Internet is highly utilized for … Continue reading
Posted in Social Media
3 Comments